Genetic Signatures: Applies to sell COVID-19 detection kits in Europe and Australia
- COVID-19 test supplier, Genetic Signatures has submitted applications to sell its rapid coronavirus detection kits in Australia and Europe
- Genetic has developed a SARS-CoV-2 specific test, also using its 3base technology
- Using its technology, Genetica can test up to 188 patient samples in just 4.5 hours
- Then the company is prepared for the anticipated high orders it will receive for the kits
- Then Genetic has recently increased its capabilities in Europe and are ready to serve hospitals and test labs across the U.K. and European Union
- Genetic is up 34.6 per cent on the market today, trading for $1.48
